In a systematic study on In order to estimate the recurrence risk to sibs of a previously diagnosed patient with early manifesting ADPKD, we found that 15 out of a total of 65 sibs of the 64 index patients (45% of the theoretically expected 32 5 gene carriers) showed comparable early manifestation. Another 10 symptom free children were diagnosed sonographically as having ADPKD before the age of 18 years, so that the total number of affected sibs was 25/65 in the study group, representing 76% of the gene carriers. Although the gene in childhood manifesting ADPKD can be transmitted through both sexes, a statistically significant (p < 0 05) maternal predominance was observed (M:F = 23:41). In affected sibs ages of onset, initial presentation, and the development of complications appeared to be similar in the majority of families.
Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common dominantly inherited conditions with an estimated incidence of 1 in 1000.' It is a major cause of chronic renal failure in adults and has gained increasing importance in paediatric nephrology. Although the age of clinical onset of this disorder is typically in the third to fifth decade of life, early manifestations of ADKPD are now well known,2 and some cases with prenatal onset have even been reported.3 At a rough estimate, about 2% of gene carriers present with severe early manifestation in childhood. 45 In clinical practice, ADPKD is as common as autosomal recessive polycystic kidney disease in children.
These cases with early clinical manifestation, however, have to be differentiated from those with a typical onset in adulthood which can already be identified by ultrasound in childhood. Bear et al6 recently reported that in about 30% of persons at risk the diagnosis of ADPKD can be established sonographically before the age of 10 years, while Coto et al7 were unable to detect renal cysts on ultrasound in 40% of disease carriers younger than 30 years. Within the past 10 to 15 years a greater awareness of the disease in affected families has been achieved, facilitated by earlier detection of symptom free patients by ultrasonography and genetic testing.
Numerous reports on early manifestations of ADKPD exist, including a considerable number of cases mainly published because of a high incidence of pre-and postnatal complications. The mechanism of early manifestation is still unclear and different theories have been suggested.89 Affected sibs have either been described as single case reports or as a part of a more general analysis of ADPKD (table   1) .2458 [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] Although a higher than expected recurrence risk of early onset ADPKD has been postulated before,5 17 14 17 20 whereas a large number of affected sibs were diagnosed by ultrasound in childhood or young adulthood merely because of their family history without showing clinical symptoms initially.8 14 1720>22
Taitz et al8 found a bimodal onset distribution in their study group and subdivided their cases into those detected by ultrasound aged 1 to 14 years because of a positive family history (group 1, n= 6) and those presenting with renal masses at birth (group 2, n = 4) who had a bad prognosis. They claimed that these were different entities and discussed several possible explanations. The gender of the parent might determine the newborn manifestation of ADPKD but this seemed to be ruled out because of the equal distribution of affected fathers and mothers in the reported cases. Homozygosity for the ADPKD mutation in children with the rare neonatal presentation (estimated incidence 6 to 12 per million)'8 appeared to be unlikely, since no case had been reported where both parents were affected. Ultimately, the authors suggested that these severely affected children might be heterozygous for both the autosomal dominant and recessive types of polycystic kidney disease, which would be consistent with the apparent frequency of renal masses at birth as a result of ADPKD. Meanwhile 20 Although transmission of the responsible mutation through both mothers and fathers of affected children has been observed, and no definite genetic imprinting effect for early manifesting ADPKD has been described yet, a predominance of transmitting mothers was noted in our study group. The father:mother ratio of 1:1 78 (23:41) in this study group with early manifestation of ADPKD suggests a maternal effect with increasing severity of ADPKD in the affected offspring. Owing to the mode of ascertainment, however, some form of bias cannot be completely excluded.
Kaariainen'7 made a similar observation in 11 families with ADPKD in children, as the mother was affected in seven families and the father in only four. Further investigations are therefore required in order to clarify the role of parental gender in the expression of the gene for ADPKD.
The results of our study are important for genetic counselling of families in whom the first child with early onset ADPKD is born. The probability that a gene carrier whose sibs showed early manifestation of ADPKD will suffer from a similar form of ADPKD is 45% 
